Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone vs. Spironolactone in Primary Aldosteronism
NCT06164379Phase 4Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in primary aldosteronism (PA), sponsored by Shanghai Jiao Tong University School of Medicine. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT06164379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164379.